Future Virology

Good and bad sides of viruses in Type 1 diabetes
pp. 407-410(4)
Authors: Filippi, Christophe M; von Herrath, Matthias G

Systematic approach to the treatment of HCV infection in injection drug users: where are we now?
pp. 411-413(3)
Authors: Conway, Brian; Tossonian, Harout K; Raffa, Jesse D; Storms, Michelle; Duncan, Fiona; Grebely, Jason

News in brief
pp. 415-417(3)

Towards a broadly active flavivirus therapeutic antibody
pp. 419-422(4)
Authors: Throsby, Mark; de Kruif, John

Update on HIV viral-load assays: new technologies and testing in resource-limited settings
pp. 423-430(8)
Authors: de Mendoza, Carmen; Soriano, Vincent

Raising awareness of human papillomavirus and cervical cancer prevention: the need for clinical education
pp. 431-436(6)
Author: Szarewski, Anne

Chronic hepatitis B and C: update on therapy
pp. 437-452(16)
Authors: Gonzalez, Stevan A; Keeffe, Emmet B

Prospects for future therapy of HCV infection
pp. 453-462(10)
Authors: Sakamoto, Naoya; Wu, George Y

HCV NS2/3 protease: a future antiviral drug target?
pp. 463-472(10)
Authors: Welbourn, Sarah; Pause, Arnim

Origins of membrane vesicles generated during replication of positive-strand RNA viruses
pp. 473-485(13)
Authors: Cottam, Eleanor; Pierini, Roberto; Roberts, Rebecca; Wileman, Thomas

Role of lipid rafts in virus infection
pp. 487-500(14)
Authors: Upla, Paula; Hyypiä, Timo; Marjomäki, Varpu

Global epidemiology of Enterovirus 71
pp. 501-510(10)
Authors: Tong, CY William; Bible, Jon M

Acknowledgements
pp. 515-515(1)